EMA Authorised: Pomalidomide Accord (Pomalidomide) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Pomalidomide Accord for the treatment of multiple myeloma. This authorisation adds a pomalidomide option to the market from Accord Healthcare S.L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide Accord (pomalidomide)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. MAH: Accord Healthcare S.L.U.. Decision date: 26/07/2024